Clariane Bundle
Who Owns Clariane SE?
Clariane SE, a major European player in long-term care, underwent a significant €329 million capital increase in mid-2024. This move brought in new major shareholders, altering the company's ownership structure. Understanding who owns Clariane is key to grasping its strategic direction and accountability.
Established in 2003, Clariane has grown into a vast network of care facilities across Europe. Its journey reflects a commitment to providing comprehensive support for seniors and vulnerable individuals, a mission detailed further in its Clariane PESTEL Analysis.
As of the close of 2024, Clariane managed 666 nursing homes, 277 specialized healthcare facilities, and 373 shared homes. The company reported revenues of €5,282 million in 2024, solidifying its position in the European market.
Who Founded Clariane?
Clariane SE, initially established as Korian in 2003, was formed through the strategic merger of four existing medical-social facility networks in Besançon, France. While the precise details of individual founders and their initial equity stakes are not publicly disclosed, this consolidation aimed to create a leading European entity focused on comprehensive care for individuals requiring long-term support. The company's journey into public ownership began with its listing on Euronext Paris on November 23, 2006, at an IPO price of €34.50 per share.
| Event | Date | Details |
|---|---|---|
| Formation as Korian | 2003 | Merger of four medical-social facility networks |
| Euronext Paris Listing | November 23, 2006 | IPO price of €34.50 |
Clariane's origins trace back to 2003 with the formation of Korian. This marked the consolidation of existing care facilities, laying the foundation for a unified approach to long-term care services.
Early strategic moves included significant acquisitions in Germany and Italy. These acquisitions, such as Phönix and Segesta, underscored an immediate focus on expanding its European footprint and diversifying its service offerings.
The company's debut on Euronext Paris in November 2006 signified a critical step towards public ownership. This IPO provided capital for further growth and established a framework for broader shareholder participation.
The core vision at inception was to establish a preeminent European provider of comprehensive care for dependent individuals. This ambition guided early strategic decisions and the company's overall development trajectory.
The initial phase of growth was characterized by strategic acquisitions across Europe. These moves were instrumental in building scale and expertise, setting the stage for Clariane's future market presence.
The IPO in 2006 not only provided liquidity but also initiated a diversified ownership structure. This public listing meant that ownership would subsequently be influenced by market dynamics and investor interest.
The early stages of Clariane's development were marked by a strategic approach to building scale and expertise within the long-term care sector. The company's formation through a merger of existing networks provided an immediate base of operational experience. Following its public listing, the ownership structure began to evolve, influenced by the capital requirements for its ambitious European expansion and the broader dynamics of the stock market. Understanding the Mission, Vision & Core Values of Clariane provides context for the strategic decisions that shaped its early ownership landscape.
The initial ownership of Clariane was shaped by its formation as Korian and its subsequent transition to a publicly traded company. This period laid the groundwork for its current shareholder structure.
- Formation through a merger of four networks in 2003.
- No publicly detailed individual founder equity splits.
- Listed on Euronext Paris on November 23, 2006.
- IPO price was €34.50 per share.
- Early growth fueled by strategic acquisitions in Germany and Italy.
- Established a foundation for a diversified ownership structure.
Clariane SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Clariane’s Ownership Changed Over Time?
Clariane SE's ownership landscape has been significantly reshaped by strategic capital increases in 2024. These actions were designed to bolster the company's financial foundation and support its long-term strategic objectives.
| Shareholder | Stake as of July 5, 2024 | Stake as of December 31, 2024 |
|---|---|---|
| Predica Prévoyance Dialogue du Crédit Agricole SA | 26.00% | 26.03% |
| Ker Holding (HLD) | 25.20% | 25.20% |
| Flat Footed LLC | 12.88% | 12.90% |
| Leima Valeurs A.S. | 5.60% | 5.602% |
The ownership structure of Clariane SE reflects a blend of significant institutional backing and a substantial retail investor base. Following capital increases in 2024, where entities like HLD Europe, Flat Footed, and Leima Valeurs participated, the company's shareholder composition has solidified. As of May 26, 2025, retail investors collectively hold approximately 46% of the company's shares, underscoring their importance in the Clariane company structure. Institutional investors, encompassing various investment funds, manage around 10% of the ownership. The total number of outstanding shares for the Group stood at 356,754,459 as of June 22, 2025. These shifts in Clariane stock ownership are integral to the company's strategy to enhance its financial flexibility and pursue its corporate goals.
Clariane's ownership is characterized by a significant presence of both institutional and individual investors. This diverse shareholder base influences the company's strategic direction and governance.
- Predica Prévoyance Dialogue du Crédit Agricole SA is a key institutional holder.
- Ker Holding (HLD) represents another substantial stake in the company.
- Retail investors collectively own a significant portion of Clariane's shares.
- The company's financial strategy is supported by these major stakeholders.
- Understanding the Revenue Streams & Business Model of Clariane provides context for ownership interests.
Clariane PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Clariane’s Board?
Clariane SE's governance is overseen by a 15-member Board of Directors, tasked with navigating the company's current and future challenges. As of May 14, 2025, Sylvia Metayer, an Independent Director since June 2024, chairs the Board, succeeding Jean-Pierre Duprieu. Sophie Boissard holds the position of Chief Executive Officer.
| Board Member | Role | Affiliation/Key Role |
|---|---|---|
| Sylvia Metayer | Chairwoman of the Board | Independent Director |
| Sophie Boissard | Chief Executive Officer | CEO |
| Matthieu Lance | Director | |
| Florence Barjou | Director | Representative of Predica |
| Jean-Bernard Lafonta | Director | Representative of HLD Europe |
| Ondřej Novák | Director | Representative of Leima Valeurs |
| Olivier Bogillot | Director | Appointed May 14, 2025 (3-year term) |
The voting power within Clariane SE generally follows the standard one-share-one-vote principle applicable to companies listed on Euronext Paris. While no specific dual-class share structures or golden shares are publicly detailed, the significant stakes held by institutional investors such as Predica, HLD Europe, Flat Footed, and Leima Valeurs indicate a concentrated influence on corporate decisions. These major shareholders have demonstrated their commitment and strategic alignment by agreeing to subscribe to capital increases, underscoring their substantial role in Clariane ownership and its Growth Strategy of Clariane. The company's governance framework is further supported by specialized committees, including the Audit Committee and the Compensation and Human Resources Committee, which aid the Board in its oversight responsibilities.
Understanding Clariane ownership reveals a structure influenced by key institutional investors. These entities play a crucial role in the company's strategic direction and financial stability.
- Clariane operates under a one-share-one-vote principle.
- Major shareholders include Predica, HLD Europe, Flat Footed, and Leima Valeurs.
- These investors have committed to capital increases, showing strategic alignment.
- The Board of Directors, led by Chairwoman Sylvia Metayer, oversees governance.
- Sophie Boissard serves as the Chief Executive Officer.
Clariane Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Clariane’s Ownership Landscape?
Over the past few years, Clariane SE has seen significant shifts in its ownership and financial strategy, driven by substantial capital increases and asset disposals. These moves have reshaped its major shareholder base and strengthened its financial resilience.
| Development | Date/Period | Impact |
|---|---|---|
| Financial Structure Strengthening Plan | Announced November 2023, progressing 2024-2025 | €1.5 billion plan to enhance financial stability |
| Reserved Capital Increase | Completed by July 2024 | €92.1 million raised |
| Capital Increase with Preferential Subscription Rights | Completed by July 2024 | €237 million raised |
| Asset Disposal Program | Ongoing, €504 million gross proceeds finalized in 2025 | Geographical refocusing and debt reduction |
| Net Debt Reduction | By end of 2024 | €409 million reduction (pre IFRS 16 and IAS 17) |
| Chairwoman Appointment | May 14, 2025 | Sylvia Metayer appointed |
The company's recent financial maneuvers have attracted significant investment, notably from HLD Europe, Flat Footed, and Leima Valeurs, alongside continued backing from Crédit Agricole Assurances (Predica). These capital injections, totaling over €329 million from the two 2024 capital increases alone, have been instrumental in altering the Clariane ownership structure. Concurrently, the €1 billion asset disposal program, which generated €504 million in gross proceeds by 2025, supports a strategic geographical refocusing and a substantial reduction in net debt, amounting to €409 million by the close of 2024. This period also saw a leadership transition with Sylvia Metayer assuming the role of Chairwoman of the Board of Directors on May 14, 2025, underscoring a strategic direction focused on financial stability and operational optimization.
Major institutional investors like HLD Europe and Flat Footed have increased their stake. Crédit Agricole Assurances (Predica) also continues its support.
The company is actively strengthening its financial structure through capital increases and asset disposals. This aims to reduce debt and improve its overall financial health.
A significant asset disposal program has led to a substantial reduction in net debt. This aligns with the company's goal of deleveraging its balance sheet.
Sylvia Metayer's appointment as Chairwoman signifies a leadership shift. This is part of the ongoing strategic navigation for the company.
Clariane Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of Clariane Company?
- What is Competitive Landscape of Clariane Company?
- What is Growth Strategy and Future Prospects of Clariane Company?
- How Does Clariane Company Work?
- What is Sales and Marketing Strategy of Clariane Company?
- What are Mission Vision & Core Values of Clariane Company?
- What is Customer Demographics and Target Market of Clariane Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.